High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome
- 1 February 2008
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 366 (1) , 1-7
- https://doi.org/10.1016/j.bbrc.2007.11.077
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Technology Insight: can autoantibody profiling improve clinical practice?Nature Clinical Practice Rheumatology, 2007
- Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems)Biochemical and Biophysical Research Communications, 2007
- Antibodies against glutamic acid decarboxylase: prevalence in neurological diseasesJournal of Neurology, Neurosurgery & Psychiatry, 2001
- A Patient with Type 1 Diabetes Mellitus and Cerebellar Ataxia Associated with High Titer of Circulating Anti-Glutamic Acid Decarboxylase Antibodies.Endocrine Journal, 2001
- Radioimmunoassay for Glutamic Acid Decarboxylase (GAD65) Autoantibodies as a Diagnostic Aid for Stiff-Man Syndrome and a Correlate of Susceptibility to Type 1 Diabetes MellitusMayo Clinic Proceedings, 1998
- Inhibition of γ‐aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff‐man syndromeAnnals of Neurology, 1998
- Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.The Journal of Experimental Medicine, 1994
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man SyndromeNew England Journal of Medicine, 1990
- Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodiesDiabetologia, 1988